Cargando…

Is Multiple System Atrophy a Prion-like Disorder?

Multiple system atrophy (MSA) is a rapidly progressive, fatal neurodegenerative disease of uncertain aetiology that belongs to the family of α-synucleinopathies. It clinically presents with parkinsonism, cerebellar, autonomic, and motor impairment in variable combinations. Pathological hallmarks are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jellinger, Kurt A., Wenning, Gregor K., Stefanova, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472631/ https://www.ncbi.nlm.nih.gov/pubmed/34576255 http://dx.doi.org/10.3390/ijms221810093

Ejemplares similares

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
por: Kaindlstorfer, Christine, et al.
Publicado: (2018)

Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014)

Animal models of multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2015)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Current experimental disease-modifying therapeutics for multiple system atrophy
por: Lemos, Miguel, et al.
Publicado: (2021)

Commentary: Discriminating α-synuclein strains in parkinson's disease and multiple system atrophy
por: Fellner, Lisa, et al.
Publicado: (2020)

Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges
por: Ndayisaba, Alain, et al.
Publicado: (2019)

Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy
por: Campese, Nicole, et al.
Publicado: (2021)

Heterogeneity of Multiple System Atrophy: An Update
por: Jellinger, Kurt A.
Publicado: (2022)

Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013)

Review: Multiple system atrophy: emerging targets for interventional therapies
por: Stefanova, N., et al.
Publicado: (2016)

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy(1)
por: Jellinger, Kurt A.
Publicado: (2018)

Correction to: Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy
por: Campese, Nicole, et al.
Publicado: (2021)

Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy
por: Sturm, Edith, et al.
Publicado: (2016)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Multiple system atrophy with hippocampal pathology
por: Jellinger, Kurt A.
Publicado: (2022)

Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and Neuroprotection
por: Stemberger, Sylvia, et al.
Publicado: (2011)

Evaluation of Multiple System Atrophy Subtypes with FDG-PET
por: Jellinger, Kurt
Publicado: (2021)

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2012)

Multiple System Atrophy: Genetic or Epigenetic?
por: Sturm, Edith, et al.
Publicado: (2014)

A Mouse Model of Multiple System Atrophy: Bench to Bedside
por: Stefanova, Nadia
Publicado: (2022)

Tremor in Multiple System Atrophy – a review
por: Kaindlstorfer, Christine, et al.
Publicado: (2013)

An update on the cerebellar subtype of multiple system atrophy
por: Ciolli, Ludovico, et al.
Publicado: (2014)

Distinct Parameters in the EEG of the PLP α-SYN Mouse Model for Multiple System Atrophy Reinforce Face Validity
por: Härtner, Lorenz, et al.
Publicado: (2017)

Signs of early cellular dysfunction in multiple system atrophy
por: Herrera‐Vaquero, M., et al.
Publicado: (2020)

Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
por: Heras‐Garvin, Antonio, et al.
Publicado: (2018)

Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications
por: Kaindlstorfer, Christine, et al.
Publicado: (2015)

Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2016)

TNFα inhibitors as targets for protective therapies in MSA: a viewpoint
por: Ndayisaba, Alain, et al.
Publicado: (2019)

Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2015)

A Review on the Clinical Diagnosis of Multiple System Atrophy
por: Stankovic, Iva, et al.
Publicado: (2022)

L-dopa response pattern in a rat model of mild striatonigral degeneration
por: Kaindlstorfer, Christine, et al.
Publicado: (2019)

Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies
por: Refolo, Violetta, et al.
Publicado: (2018)

Analysis of the prion protein gene in multiple system atrophy
por: Chelban, Viorica, et al.
Publicado: (2017)

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure
por: Stemberger, Sylvia, et al.
Publicado: (2010)

Genetic players in multiple system atrophy: unfolding the nature of the beast
por: Stemberger, Sylvia, et al.
Publicado: (2011)

Prions and Prion-Like Pathogens in Neurodegenerative Disorders
por: Peggion, Caterina, et al.
Publicado: (2014)

Prions, prion-like prionoids, and neurodegenerative disorders
por: Verma, Ashok
Publicado: (2016)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
por: Lemos, Miguel, et al.
Publicado: (2020)

Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: Experimental evidence
por: Kuzdas, Daniela, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1j4385g46pnmgut8na4mvrjat2